Although CES1 has been implicated in hepatic steatosis [37], a recent study has shown that CES1 may have potential as a biomarker to distinguish hepatocellular carcinoma (HCC) from cirrhosis [40]. Here, CES1 is linked to hepatocellular carcinoma.